Orphion Therapeutics
Great Neck, US · Founded 2020 · Delaware corporation
Founders & leadership
JS
Jason SlakterNamed on SEC filing
MM
Michael MashaalNamed on SEC filing
NV
Nickolay VoroninNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.3M disclosed across 1 round · 2020
▶$5.3MraisedNov 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$5.3MraisedNov 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jason SlakterExecutive Officer, Director
- Michael MashaalDirector
- Nickolay VoroninDirector
- Offering amount
- $16.3M
- Amount sold
- $5.3M
- Finders' fees
- $250K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Orphion Therapeutics raised?
- Orphion Therapeutics has disclosed $5.3M raised across 1 round.
- Where is Orphion Therapeutics headquartered?
- Orphion Therapeutics is headquartered in Great Neck, US.